Compare CYTK & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | OSK |
|---|---|---|
| Founded | 1997 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.1B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | OSK |
|---|---|---|
| Price | $64.76 | $149.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $82.38 | ★ $150.67 |
| AVG Volume (30 Days) | ★ 2.2M | 647.4K |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 10.25 |
| Revenue | $87,211,000.00 | ★ $10,331,600,000.00 |
| Revenue This Year | $346.43 | N/A |
| Revenue Next Year | $57.69 | $5.94 |
| P/E Ratio | ★ N/A | $14.69 |
| Revenue Growth | ★ 2609.26 | N/A |
| 52 Week Low | $29.31 | $76.82 |
| 52 Week High | $70.98 | $150.66 |
| Indicator | CYTK | OSK |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 69.81 |
| Support Level | $62.05 | $125.51 |
| Resistance Level | $66.59 | $150.66 |
| Average True Range (ATR) | 3.21 | 3.83 |
| MACD | 0.15 | 2.18 |
| Stochastic Oscillator | 49.01 | 95.31 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (49% of revenue), Vocational (31%), and Transport (20%) on 2024 revenue of $10.7 billion.